Here are ten useful principles for anyone reporting on Covid-19 vaccines, from communications experts new to this topic to experienced journalists.
While vaccines are the safest way to prevent the spread infectious disease, a tiny proportion of those vaccinated may experience an adverse event. Here, we explain how often this happens and why.
Unprecedented international cooperation and focus have led to multiple effective and safe Covid-19 vaccines in less than a year, and created a blueprint for future vaccine development.
The UK government recently announced that it will leave a longer gap than expected between people’s first and second doses of Covid-19 vaccine. How will that affect their efficacy?
There are hundreds of Covid-19 vaccines in development, and some have produced very positive results in phase III clinical trials. How do some of the different vaccines work and compare?
Cheryl Moore, who is currently the President and Chief Operating Officer of the New York Genome Center, is to become Wellcome’s new Director, Research Programmes.
Both the Pfizer-BioNTech and Moderna Covid-19 vaccines, unlike the vaccines we already use for other diseases, have been developed using ribonucleic acid (RNA) technology. So, how do they work, are they safe, and what else do we know about them?
We’ve been holding townhalls up and down the country – in person and then via Zoom – to hear your ideas on how research culture could be improved.
In a tumultuous year, Wellcome has been at the heart of the global scientific response to the Covid-19 pandemic, while maintaining support for our broad portfolio of research. Our 2019/20 Annual Report reveals Wellcome spent £1.1 billon on research, innovation and advocacy.